Date	Part	Topic
31 October 2008		Results of meeting
31 October 2008		Chairman's address to Shareholders
14 October 2008		Change of Director`s Interest Notice
14 October 2008		Change in substantial holding
13 October 2008		Ceasing to be a substantial holder from ANZ
30 September 2008		Notice of Annual General Meeting
30 September 2008		Proxy Form
30 September 2008		Annual Report
01 September 2008		Change of Director`s Interest Notice
28 August 2008		Change in substantial holding
15 August 2008		Preliminary final report
11 August 2008		IDT Facility Opening
21 July 2008		Change in substantial holding
21 July 2008		Change of Director's Interest Notice
9 July 2008		Response to an ASX Query re Margin Lending Facilities
8 July 2008		ANZ: Primebroker Disclosure
8 July 2008		Trading Halt Request
12 May 2008		Form 603 and 604 from ANZ
19 February 2008		Half Yearly Report and Accounts
02 January 2008		Initial Director's Interest Notice
26 October 2007		Constitution
26 October 2007		Results of Meeting
26 October 2007		Chairman's Address to Shareholders
26 October 2007		Chairman's Address to Shareholders
11 October 2007		Reply to ASX Price Query
24 September 2007		Notice of Annual General Meeting
24 September 2007		Proxy Form
24 September 2007		Annual Report
14 August 2007		Preliminary final report
6 August 2007		Appendix 3B - New Issue Announcement
20 February 2007		Half Yearly Report & Half Yearly Accounts
25 January 2007		IDT Expands Drug Development Relationship with Pfizer
12 December 2006		Response to ASX Query re Share Price
27 October 2006		Final Director's Interest Notice
27 October 2006		AGM Meeting
27 October 2006		AGM Chairman Presentation
27 October 2006		AGM Chairman Presentation
27 September 2006		Retirement of Director
26 September 2006		Notice of Annual General Meeting
26 September 2006		Proxy Form
26 September 2006		Annual Report
22 August 2006		Change of Directors Interest Notice
16 August 2006		Appendix 3B - New Issue Announcement
15 August 2006		Preliminary final report
07 June2006		Change of Director's Interest Notice 2
31 May 2006		Change of Director's Interest Notice 2
30 May 2006		Change of Director's Interest Notice 2
23 February 2006		Half Yearly Report & Half Yearly Accounts
27 January 2006		Change of Director's Interest
17 February 2006		Ceasing to be a substantial holder from AMP
24 January 2006		Change of Director's Interest
22 December 2005		IDT to expand finished product production capability
28 October 2005		AGM Voting
28 October 2005		Chairman's & MD's Address to Shareholders
28 September 2005		Notice of Annual General Meeting
28 September 2005		Proxy Form
28 September 2005		Annual Report
23 August 2005		Change in substantial holding from AMP
16 August 2005		Preliminary final report
23 June 2005		Appendix 3B - Issue of unquoted options
08 June 2005		Change of Auditor
07 June 2005		FDA Approves Facility to manufacture Thalidomide
21 April 2005		Change of Director's Interest Notice X 5
31 March 2005		Change of Director's Interest Notice
15 February 2005		Half Yearly Report & Half Yearly Accounts
18 January 2005		Company Secretary Appointment/Resignation
02 November 2004		Appendix 3B - Issue of unquoted options
29 October 2004		Results of AGM
29 October 2004		Chairman's Address
29 September 2004		Annual Report
28 September 2004		Notice of Annual General Meeting
28 September 2004		Appendix 3B - Issue of Unquoted Options
25 August 2004		Preliminary final Report
04 August 2004		Appendix 3B - Share Plan.
28 July 2004		Change in substantial holding from AMP
26 July 2004		IDT signs major contract with US Specialty Pharmaceutical Co
19 July 2004		Change of Registrar
5 July 2004		IDT To Develop & Manufacture New Drug Candidate for Pfizer
23 June 2004		Change of Director's Interest Notice
11 May 2004		SBP ann: Select CMax for Psoriasis Trials
07 May 2004		Change of Director's Interest Notice
06 April 2004		Change of Director's Interest Notice X 5
27 February 2004		Change of Director's Interest Notice
17 February 2004		Half Yearly Report & Half Yearly Accounts
6 November 2003		IDT Invests in major new manufacturing facilities
5 November 2003		News Release - Dr Graeme Blackman Honoured
31 October 2003		Chairman and Managing Director's Report
31 October 2003		Results of AGM
29 September 2003		Notice of Annual General Meeting
29 September 2003		Annual Report
16 September 2003		SPL's Ann:Alliance with IDT Ltd to Conduct Human Trials
25 August 2003		ASX Preliminary final report - 30 June 2003
07 August 2003		Appendix 3B - Issue under Share Plan
10 July 2003		Change of Director's Interest Notice
05 June 2003		Not to pursue the possibility of merger with VHL
23 May 2003		IDT Comments on Prospectus issued by Virax Holdings Ltd
29 April 2003		Comments on TGA Recall of Pan Pharmaceuticals Products
12 March 2003		Change of Director's Interest Notice
26 February 2003		Half Yearly Report & Half Yearly Accounts